Omeros Corp. Files 2024 Annual Report

Ticker: OMER · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1285819

Omeros Corp 10-K Filing Summary
FieldDetail
CompanyOmeros Corp (OMER)
Form Type10-K
Filed DateMar 31, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: annual-report, pharmaceuticals, financials

TL;DR

OMER 10-K filed for FY24. Full financial picture out now.

AI Summary

Omeros Corp. filed its 10-K for the fiscal year ending December 31, 2024, reporting on its financial performance and business operations. The company, headquartered in Seattle, WA, operates in the Pharmaceutical Preparations sector. Key financial details and operational highlights from the filing will provide insights into the company's status and future outlook.

Why It Matters

This 10-K filing provides a comprehensive overview of Omeros Corp.'s financial health and strategic direction for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and potential.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Omeros Corp. faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed within the 10-K.

Key Numbers

  • 2834 — SIC Code (Pharmaceutical Preparations industry)
  • 911663741 — EIN (Employer Identification Number)
  • 001-34475 — SEC File Number (Company's SEC filing identifier)

Key Players & Entities

  • OMEROS CORP (company) — Filer
  • 201 ELLIOTT AVENUE WEST (location) — Business and Mail Address
  • SEATTLE (location) — City
  • WA (location) — State
  • 20241231 (date) — Fiscal Year End
  • 20250331 (date) — Filing Date

FAQ

What was Omeros Corp.'s total revenue for the fiscal year ending December 31, 2024?

The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024. A detailed review of the full 10-K document is required to ascertain this information.

What is Omeros Corp.'s primary line of business?

Omeros Corp.'s primary line of business is in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification (SIC) code 2834.

Where is Omeros Corp. headquartered?

Omeros Corp. is headquartered in Seattle, WA, with its business and mail address listed as 201 Elliott Avenue West.

When was this 10-K filing submitted to the SEC?

This 10-K filing was submitted to the SEC on March 31, 2025.

What is the fiscal year end date for this report?

The fiscal year end date for this report is December 31, 2024.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding OMEROS CORP (OMER).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.